Results 161 to 170 of about 1,366,092 (327)

Contrast‐Enhanced Ultrasound Predicts Surgical Margin Positivity in Patients With Breast Cancer Who Underwent Partial Mastectomy

open access: yesWorld Journal of Surgery, EarlyView.
The clinical disadvantage of positive margins in partial mastectomy for patients with operable breast cancer is clear and must be avoided; however, there is still room for improvement. The usefulness of contrast‐enhanced ultrasound (CEUS) in diagnosing spread is currently well‐known.
Hiroaki Shima   +8 more
wiley   +1 more source

Clinicopathological Study of the Colorectal Mucinous Carcinoma

open access: bronze, 1998
Masahiko Ohata   +11 more
openalex   +2 more sources

E2F4 Promotes Malignant Behaviors of Prostate Cancer Through Activating MUC1 Expression Transcriptionally

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
E2F4 promotes malignant behaviors of prostate cancer through activating MUC1 expression transcriptionally. ABSTRACT Background The malignant features of prostate cancer (PC) threaten the patient's life. MUC1 was observably enhanced in PC. However, the reason for higher MUC1 expression in PC is still unclear and deserves to be further investigated ...
Long Cheng   +6 more
wiley   +1 more source

Intestinal‑type mucinous carcinoma of the endometrium showing a polypoidal exophytic form: A case report. [PDF]

open access: yesOncol Lett, 2023
Nakano C   +11 more
europepmc   +1 more source

A CLINICOPATHOLOGICAL STUDY OF THE COLORECTAL MUCINOUS CARCINOMA

open access: bronze, 1995
Toshihiro Morita   +7 more
openalex   +2 more sources

Impact of concomitant carcinoma in situ distribution on non‐muscle‐invasive bladder cancer progression risk

open access: yesBJU International, EarlyView.
Objective To assess whether the distribution of concomitant carcinoma in situ (CIS; unifocal or multifocal) with papillary non‐muscle‐invasive bladder cancer (NMIBC) impacts the risk of progression, as concomitant CIS is an established risk factor for progression in papillary NMIBC and commonly used calculators do not make this distinction.
Jethro C.C. Kwong   +22 more
wiley   +1 more source

Protein tyrosine phosphatases as emerging targets for cancer immunotherapy

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Contemporary strategies in cancer immunotherapy, despite remarkable success, remain constrained by inherent limitations such as suboptimal patient responses, the emergence of drug resistance, and the manifestation of pronounced adverse effects. Consequently, the need for alternative strategies for immunotherapy becomes clear.
Zihan Qu, Jiajun Dong, Zhong‐Yin Zhang
wiley   +1 more source

Home - About - Disclaimer - Privacy